SMAP200700061A - Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi - Google Patents

Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi

Info

Publication number
SMAP200700061A
SMAP200700061A SM200700061T SM200700061T SMAP200700061A SM AP200700061 A SMAP200700061 A SM AP200700061A SM 200700061 T SM200700061 T SM 200700061T SM 200700061 T SM200700061 T SM 200700061T SM AP200700061 A SMAP200700061 A SM AP200700061A
Authority
SM
San Marino
Prior art keywords
pathogenesis
role
treatment
liver diseases
iron plays
Prior art date
Application number
SM200700061T
Other languages
English (en)
Inventor
Daniele Alberti
Peter Marks
Hanspeter Nick
Lisa Grace Rojkjaer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SMAP200700061A publication Critical patent/SMAP200700061A/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SM200700061T 2005-05-31 2006-05-30 Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi SMAP200700061A (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68584805P 2005-05-31 2005-05-31
US69280805P 2005-06-22 2005-06-22
US74678606P 2006-05-09 2006-05-09
PCT/US2006/020677 WO2006130532A2 (en) 2005-05-31 2006-05-30 Treatment of liver diseases in which iron plays a role in pathogenesis

Publications (1)

Publication Number Publication Date
SMAP200700061A true SMAP200700061A (it) 2007-12-28

Family

ID=37106984

Family Applications (1)

Application Number Title Priority Date Filing Date
SM200700061T SMAP200700061A (it) 2005-05-31 2006-05-30 Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi

Country Status (16)

Country Link
US (3) US20080199428A1 (it)
EP (1) EP1893198A2 (it)
JP (2) JP2008542380A (it)
KR (2) KR20080003933A (it)
AU (1) AU2006252718B2 (it)
BR (1) BRPI0610873A2 (it)
CA (1) CA2608709A1 (it)
CR (1) CR9454A (it)
EA (1) EA014772B1 (it)
IL (1) IL187000A0 (it)
MA (1) MA29542B1 (it)
MX (1) MX2007015085A (it)
NO (1) NO20076595L (it)
SM (1) SMAP200700061A (it)
TN (1) TNSN07447A1 (it)
WO (1) WO2006130532A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
PL359169A1 (en) 2000-05-26 2004-08-23 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
KR20050035194A (ko) 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
RU2008109649A (ru) * 2005-08-15 2009-09-27 Ф.Хоффманн-Ля Рош Аг (Ch) ПЭГ-IFNα И РИБАВИРИН ДЛЯ ЛЕЧЕНИЯ ВИРУСА ГЕПАТИТА В
EP1927591A1 (en) * 2006-11-29 2008-06-04 Novartis AG Polymorphic Forms of Deferasirox (ICL670)
CA2670313C (en) 2006-11-29 2013-02-12 Novartis Ag Polymorphic forms of deferasirox (icl670a)
KR102198749B1 (ko) * 2011-03-02 2021-01-06 제롬 쉔타그 단독으로 또는 c형 간염 바이러스 감염과 결합되는 간 지방증의 치료를 위한 조성물, 방법 및 진단
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
CN104023726A (zh) 2011-10-21 2014-09-03 艾伯维公司 用于治疗hcv的一种或多种daa的联合治疗(例如,与abt-072或abt-333)
DE112012003510T5 (de) 2011-10-21 2015-03-19 Abbvie Inc. Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
EA038594B1 (ru) * 2011-10-28 2021-09-21 Шайр Хьюман Дженетик Терапис, Инк. Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
CA2941411A1 (en) * 2014-03-21 2015-09-24 Tobira Therapeutics, Inc. Cenicriviroc for the treatment of fibrosis
JP7129703B2 (ja) 2016-04-28 2022-09-02 エモリー ユニバーシティー アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
JP4125011B2 (ja) * 2002-01-22 2008-07-23 株式会社 伊藤園 過剰鉄起因肝障害予防・治療剤及び過剰鉄起因肝障害予防・治療飲食物

Also Published As

Publication number Publication date
KR20080003933A (ko) 2008-01-08
EA200702384A1 (ru) 2008-06-30
JP5869469B2 (ja) 2016-02-24
KR101174966B1 (ko) 2012-08-17
MX2007015085A (es) 2008-01-17
KR20100018057A (ko) 2010-02-16
TNSN07447A1 (en) 2009-03-17
US20080199428A1 (en) 2008-08-21
MA29542B1 (fr) 2008-06-02
WO2006130532A2 (en) 2006-12-07
CA2608709A1 (en) 2006-12-07
JP2013082726A (ja) 2013-05-09
AU2006252718A1 (en) 2006-12-07
CR9454A (es) 2008-04-16
US20130109730A1 (en) 2013-05-02
BRPI0610873A2 (pt) 2010-08-03
JP2008542380A (ja) 2008-11-27
WO2006130532A3 (en) 2007-11-22
IL187000A0 (en) 2008-02-09
US20100098662A1 (en) 2010-04-22
EA014772B1 (ru) 2011-02-28
EP1893198A2 (en) 2008-03-05
AU2006252718B2 (en) 2010-04-15
NO20076595L (no) 2007-12-20

Similar Documents

Publication Publication Date Title
IL187000A0 (en) Treatment of liver diseases in which iron plays a role in pathogenesis
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
EP1948298A4 (en) BIO-INTERVENING THERAPEUTIC TREATMENT FOR HEART DISEASE DISEASES
DE602006016150D1 (de) Vorbeugung von krankheiten bei kaiserschnitt-babies
ZA200709004B (en) Spiroheterocyclic compounds and their uses as therapeutic agents
BRPI0809272A2 (pt) Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro
EP2004194A4 (en) AZOXYSTROBINFORMULIERUNGEN
IL211904A (en) Kit and preparations containing methotrexate and anti-cd4 antibody for the treatment of rheumatic disease
ITPN20050014A1 (it) "piedino livellatore perfezionato"
EP1744740A4 (en) PHENOXYALKYCARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
DK1793692T3 (da) Antimikrobiel sammensætning
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
SI1890705T1 (sl) Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter
EP1755670A4 (en) METHOD FOR THE TREATMENT OF VASCULAR DISEASES
HU0500145D0 (en) Composition for the treatment of oral diseases
ZA200708895B (en) Treatment of liver diseases in which iron plays a role in pathogenesis
ITTO20060560A1 (it) Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii
ITFI20050076A1 (it) Forma per calzature e procedimento per la manipolazione delle forme per calzature
BRPI0720697A2 (pt) Produtos para o tratamento de clorose de ferro
FR2888750B1 (fr) Composition pour prevenir et traiter les maladies cardiovasculaires
HK1116084A (en) Treatment of liver diseases in which iron plays a role in pathogenesis
FR2877961B1 (fr) Kiosque de vente
IT1391251B1 (it) Composizione per il trattamento delle patologie articolari
SE0500053D0 (sv) Therapeutic agents 1
AT501353A3 (de) Sportschuh